🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Good job @ArndtStahler !

Manju George MVSc PhD Rectal Cancer Survivor OncoAlert You guessed it... having an opinion is not knowing it. 😉

Adding panitumumab to 5-FU and leucovorin significantly improved PFS compared with 5-FU/leucovorin alone as a maintenance therapy for patients with RAS wild-type metastatic CRC. #ASCO21 | Dominik Paul Modest cancernetwork.com/view/maintenan…

Panama trial data now available at JCO ascopubs.org/doi/pdfdirect/…

Eine interdisziplinäre klinische Studie zur Therapie von #Darmkrebs startet nun unter Leitung der #CharitéBerlin. Die FIRE-9/PORT-Studie soll helfen, die Neuentstehung von Metastasen zu verhindern. Dominik Paul Modest Sebastian Stintzing Arbeitsgemeinschaft Internistische Onkologie - AIO @LMU_Uniklinikum charite.de/service/presse…

Our new podcast series is out! In Episode 2 Jenny Seligmann, Autumn McRee and Dominik Paul Modest are discussing #immunotherapy approaches! Listen to the podcast and download the transcript at: ow.ly/erC950GKbN6 #MedEd #GI #GC

The protocol of the PORT trial is published, which aims to generate evidence that post-resection/ablation/radiation chemotherapy improves the survival in patients with metastatic colorectal cancer. bmccancer.biomedcentral.com/articles/10.11… Dominik Paul Modest Charité | Experimental Surgery

Endlich wieder (zumindest teilweise) in Präsenz. Die 15. Frühjahrstagung ist als Hybrid-Veranstaltung in vollem Gange! 🤩 aio.konferenz-hub.de Anke Reinacher-Schick Sebastian Stintzing Dominik Paul Modest Michael Quante Kathrin Heinrich @ArndtStahler JobstEinem und viele mehr!

Reporting from #Chicago at #ASCO22 : the #YMO of #AIO - today educational sessions in GI oncology and oral session metastatic #NSCLC @ArndtStahler Kathrin Heinrich Anke Reinacher-Schick Sebastian Stintzing Dominik Paul Modest

Proud to present our subgroup analysis of the PANAMA-study according to #gender and age in patients with #colorectalcancer at #ASCO2022! Thanks to my amazing mentors Dominik Paul Modest and Sebastian Stintzing for their support!

Today at #ASCO22 #CRC Poster discussion: how to handle #antiEGFR #rechallenge in #CRC? including results of the Phase III trial FIRE-4, discussed by Sebastian Stintzing and colleagues . Congratulations! Dominik Paul Modest @ArndtStahler Kathrin Heinrich Ben Westphalen

Well said Filippo Pietrantonio …and ESMO - Eur. Oncology #ESMO22 is approaching fast!

Great to see randomized data. Congratulations!! Great achievement. Final conclusion (do it or not) more complex. Data suggest that HIPEC influences local but not systemic control and systemic relapse is a frequent issue.

💥💥💥💥Myriam Chalabi #ESMO22 discussing NICHE2 - neoadjuvant nivo/ipi in locally advanced colon cancer 💥short duration safe pre-op 💥4% grade 3 events 💥100% R0 resection 💥95% major path; 67% pCR …round of applause in session! 1/2

Niche-2. No need for further interpretation… congrats to Myriam!! What a perfect presentation of a super trial. Great that we had a wowww moment in colon cancer.

Five GI CONNECT experts provide a handy update from #ESMO2022! ➡️ Podcast Ep. 1: Lower #GIcancer highlights ➡️ Podcast Ep. 2: Upper #GIcancer highlights ➡️ Video summary of NICHE-2 trial For the podcasts, video and downloadable content, follow: ow.ly/6GQF50L2EhI #MedEd

Original Article: Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C (CodeBreaK 300 phase 3 trial) nej.md/3M8Qw3k #ESMO23 #oncology

Voting open for ESMO - Eur. Oncology #president 2027-2028! Vote now, or on your way to #ASCO24! My vote 👇 Nadia Harbeck,MD PhD #mentor #strong #womenleaders #femalepresident

🚨 #LowerGIcancer highlights from #ASCO24 🚨 Prof. Jenny Seligmann & Dr Dominik Paul Modest share their views on new data from #COLLISION & #TRANSMET trials presented at the congress. ⬇️🎥⬇️ #MedEd #ASCOhighlights #CRCSM #LowerGI

🚨#LowerGIcancer highlights from #ASCO24🚨 Medical oncologists Prof. Jenny Seligmann and Dr Dominik Paul Modest share their views on new data in #rectalcancer and #CRC from the NEOPRISM-CRC trial & LBA3512. Watch the video 📺 👇 #MedEd #oncology #CRCSM